Advanced liver damage could be treated and repaired instead
of requiring a transplant thanks to a University of Edinburgh spinout company. Resolution
Therapeutics Ltd is based on a decade of research from the Forbes lab at the
Centre for Regenerative Medicine.
It has received funding of £26.6 million from Syncona Ltd, a
specialist healthcare investment company. The investment is expected to enable
Resolution to gain early clinical data for its first product.
www.ed.ac.uk/regenerative-medicine/news-events/latest-news/cell-therapy-spinout-liver-repair